肝X受体
非酒精性脂肪肝
基因沉默
化学
小RNA
转录因子
抄写(语言学)
脂质代谢
内科学
内分泌学
癌症研究
脂肪肝
生物
生物化学
医学
基因
疾病
核受体
哲学
语言学
作者
Feizhou Huang,Huaizheng Liu,Lei Zhao,Zhenzhou Li,Tianyi Zhang,Mingshi Yang,Kefu Zhou,Chuanzheng Sun
摘要
Abstract Nonalcoholic fatty liver disease (NAFLD) is regarded as a threat to public health; however, the pathologic mechanism of NAFLD is not fully understood. We attempted to identify abnormally expressed long noncoding RNA (lncRNAs) and messenger RNA that may affect the occurrence and development of NAFLD in this study. The expression of differentially expressed lncRNAs in NAFLD was determined in oleic acid (OA)‐treated L02 cells, and the functions of CCAT1 in lipid droplet formation were evaluated in vitro. Differentially expressed genes (DEGs) were analyzed by microarray analysis, and DEGs related to CCTA1 were selected and verified by weighted correlation network analysis. The dynamic effects of LXRα and CCTA1 on lipid droplet formation and predicted binding was examined. The binding between miR‐631 and CCAT1 and LXRα was verified. The dynamic effects of miR‐613 inhibition and CCTA1 silencing on lipid droplet formation were examined. The expression and correlations of miR‐631, CCAT1, and LXRα were determined in tissue samples. As the results show, CCAT1 was induced by OA and upregulated in NAFLD clinical samples. CCAT1 silencing significantly suppressed lipid droplet accumulation in vitro. LXRα was positively correlated with CCAT1. By inhibiting miR‐613, CCAT1 increased the transcription of LXRα and promoted LXRα expression. The expression of LXRα was significantly increased in NAFLD tissues and was positively correlated with CCAT1. In conclusion, CCAT1 increases LXRα transcription by serving as a competing endogenous RNA for miR‐613 in an LXRE‐dependent manner, thereby promoting lipid droplet formation and NAFLD. CCAT1 and LXRα might be potent targets for NAFLD treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI